Previous Article | Next Article ![]()
J. Virol., Oct 1997, 7827-7831, Vol 71, No. 10
MJ Selby, B Doe and CM Walker
Cytotoxic T lymphocyte (CTL) activity was assessed in mice immunized with
DNA plasmids containing the human immunodeficiency virus type 1 (HIV-1)
gp120 envelope (pTMIgp120) or p55gag (pTMIgag) gene regulated by the
bacteriophage T7 promoter. Immunization with either plasmid resulted in CTL
activity against class I major histocompatibility complex-restricted viral
epitopes when coadministered with a recombinant vaccinia virus expressing
the T7 RNA polymerase protein (T7 RNAP) but not a control vaccinia virus.
Recombinant vaccinia-T7 RNAP virus (VTF7-3) could be replaced with a
noninfectious source of T7 RNAP. A three-component vaccine consisting of
pTMIgag, a recombinant subunit T7 RNAP protein, and a plasmid (pT7T7)
encoding T7 RNAP under the control of its own promoter induced gag-specific
CTL activity. Intramuscular immunization with the pTMIgag plasmid delivered
with either the T7 RNAP protein or pT7T7 plasmid alone also induced HIV-1-
specific CTL. Thus, there is adventitious expression of the pT7T7 plasmid
in vivo, and enough T7 RNAP is produced to result in production of p24gag
protein from the pTMIgag plasmid. The results demonstrate that regulated
expression of genes in vivo is possible with this T7- based expression
system, and may be useful in vaccine settings where short-term cytoplasmic
expression of protein in antigen presenting cells is desired.
Copyright © 1997, American Society for Microbiology
Virus-specific cytotoxic T-lymphocyte activity elicited by coimmunization with human immunodeficiency virus type 1 genes regulated by the bacteriophage T7 promoter and T7 RNA polymerase protein
Chiron Corporation, Emeryville, California 94608, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»